WALTHAM, Mass., Sept. 19 (Korea Bizwire) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and ...
Some results have been hidden because they may be inaccessible to you